Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Investment: Sharewatch

Tuesday 02 March 1999 19:02 EST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

BUY

Nyomed Amersham's (386p) earnings should grow by 13 per cent during the next five years, says Morgan Stanley Dean Witter, which has upgraded the shares to a strong buy, with a target price of 525p. Nycomed is well placed to benefit from the growing tendency to outsource pharmaceutical research and development over the next decade, it adds. The industrial logic behind the BTR Siebe (269p) merger is sound, says Charles Stanley, and benefits will be apparent over time.

SELL

Although WH Smith's (528p) profits should grow strongly during the course of the next two years, it could soon be time to sell into strength, Henderson Crosthwaite says.

In the longer-term, there is a question mark on the profitability of the High Street stores (50 per cent of group profit) which even fast-growing online services would only partly offset.

Sell South African Breweries (473p), says SG Equity Research, noting that economic and policitical risks will impact on the shares much more than SAB's growth record in local markets.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in